originally published Sunday, October 08, 2017

Printable Version

All Biotech & Medical Stocks

We called this one correctly again and it has done well, having broken out upside from its bull Flag after we bought back into it, and we are up over 28% in a week. Now supercritically overbought again so considered prudent to TAKE PROFITS in the early trade this coming Monday, when, with a bit of luck, it will open higher, and perhaps drop back later in the day. The fundamentals of this company are great, but as we have found to our cost on occasion, that won’t necessarily stop it reacting back when investors suffer from a mood swing. In any case, we can always buy it back on a reaction if it looks promising again, if there is one.

Helius Medical Technologies website

Helius Medical Technologies Inc, HSM.TSX, HSDT on OTC, closed at C$4.50, $3.56 on 6th October 17.

Posted at 5.30 am EDT on 8th October 17.

The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stockmarket analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks can only be construed as a solicitation to buy and sell securities when they are subject to the prior approval and endorsement of a Registered Securities Advisor operating in accordance with the appropriate regulations in your area of jurisdiction.